Oct 01, 2021 · This is the American ICD-10-CM version of Z79.811 - other international versions of ICD-10 Z79.811 may differ. Applicable To Long term (current) use of anastrozole (Arimidex)
Oct 01, 2021 · 2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code. T88.7 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. The 2022 edition of ICD-10 …
Oct 01, 2021 · Z79.811 is a valid billable ICD-10 diagnosis code for Long term (current) use of aromatase inhibitors . It is found in the 2022 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2021 - Sep 30, 2022 . POA Exempt.
Apr 16, 2018 · With the implementation of ICD-10-CM came more codes for reporting the long-term use of drugs. There is now a code to report long-term use (LTU) of aromatase inhibitors. ... • Arimidex/anastrozole • Aromasin/exemestane • Femara/letrozole. There are times when premenopausal women may be placed on an aromatase inhibitor. In those cases, the ...
If the Arimidex and/or Tamoxifen is being used to prevent cancer recurrence then you'd code it as personal history of breast neoplasm (Z85.3) along with the Z79.811 or Z79.810 (depending on if they're receiving Arimidex or Tamoxifen). If the oral drug is being used as anti-hormonal treatment then code the cancer as active disease along with the appropriate Z79 code. Hope this helps!
Class: Aromatase inhibitor hormonal therapy . Aromasin and Femara are other aromatase inhibitors. Uses: Arimidex, used to treat postmenopausal women, typically is used to: • reduce the risk of early-stage, hormone-receptor-positive breast cancer coming back after surgery and other treatments.
ARIMIDEX is approved for the initial treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer and for the treatment of postmenopausal women with advanced breast cancer that has progressed following treatment with tamoxifen. Patients with hormone receptor-negative ...
Uses: Arimidex, used to treat postmenopausal women, typically is used to: • reduce the risk of early-stage, hormone-receptor-positive breast cancer coming back after surgery and other treatments. • treat advanced-stage, hormone-receptor-positive breast cancer.
Arimidex usually is taken for 5 years. Doctors may recommend that some women take it for a longer or shorter period of time. Chemical name: Tamoxifen.
Tamoxifen usually is taken for up to 5 years, but women with advanced-stage breast cancer may continue taking tamoxifen as long as it is working well. To me it seems like it is stating that it can be used both for Active Breast Cancer and as a Preventative when it is not "Active".